Influenza a virus infection causes chronic lung disease linked to sites of active viral RNA remnants

Journal of Immunology

Volumn 201, Issue 8, 2018, Pages 2354-2368

  Keeler, Shamus P ^a   Agapov, Eugene V ^a   Hinojosa, Michael E ^a   Letvin, Adam N ^a   Wu, Kangyun ^a   Holtzman, Michael J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IL17A PROTEIN, MOUSE; INTERLEUKIN 13; INTERLEUKIN 17; MUC5AC PROTEIN, MOUSE; MUCIN 5AC; STAT6 PROTEIN; VIRUS RNA;

ANIMAL; BRONCHUS; BRONCHUS HYPERREACTIVITY; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS; KNOCKOUT MOUSE; LUNG; LUNG DISEASE; METABOLISM; METAPLASIA; MOUSE; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; PHYSIOLOGY; VIROLOGY; VIRUS LOAD;

ANIMALS; BRONCHI; BRONCHIAL HYPERREACTIVITY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INTERLEUKIN-13; INTERLEUKIN-17; LUNG; LUNG DISEASES; METAPLASIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCIN 5AC; ORTHOMYXOVIRIDAE INFECTIONS; RNA, VIRAL; STAT6 TRANSCRIPTION FACTOR; VIRAL LOAD;

EID: 85054772691     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1800671     Document Type: Article

References (96)

1. Holtzman, M. J. 2012. Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. J. Clin. Invest. 122: 2741-2748.
2. Sigurs, N., P. M. Gustafsson, R. Bjarnason, F. Lundberg, S. Schmidt, F. Sigurbergsson, and B. Kjellman. 2005. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 171: 137-141.
3. Castro, M., T. Schweiger, H. Yin-DeClue, T. P. Ramkumar, C. Christie, J. Zheng, R. Cohen, K. B. Schechtman, R. Strunk, and L. B. Bacharier. 2008. Cytokine response after severe respiratory syncytial virus bronchiolitis in early life. J. Allergy Clin. Immunol. 122: 726-733.e3.
4. Guilbert, T. W., A. M. Singh, Z. Danov, M. D. Evans, D. J. Jackson, R. Burton, K. A. Roberg, E. L. Anderson, T. E. Pappas, R. Gangnon, et al. 2011. Decreased lung function after preschool wheezing rhinovirus illnesses in children at risk to develop asthma. J. Allergy Clin. Immunol. 128: 532-538.e1-10.
5. Kan-O, K., R. Ramirez, M. I. MacDonald, M. Rolph, P. A. Rudd, K. M. Spann, S. Mahalingam, P. G. Bardin, and B. J. Thomas. 2017. Human metapneumovirus infection in chronic obstructive pulmonary disease: impact of glucocorticosteroids and inteferon. J. Infect. Dis. 215: 1536-1545.
6. Footitt, J., P. Mallia, A. L. Durham, W. E. Ho, M. B. Trujillo-Torralbo, A. G. Telcian, A. Del Rosario, C. Chang, H.-Y. Peh, T. Kebadze, et al. 2016. Oxidative and nitrosative stress and histone deacetylase-2 activity in exacerbations of COPD. Chest 149: 62-73.
7. Bønnelykke, K., A. T. Coleman, M. D. Evans, J. Thorsen, J. Waage, N. H. Vissing, C. J. Carlsson, J. Stokholm, B. L. Chawes, L. E. Jessen, et al. 2018. Cadherin-related family member 3 genetics and rhinovirus C respiratory illnesses. Am. J. Respir. Crit. Care Med. 197: 589-594.
8. Bønnelykke, K., N. H. Vissing, A. Sevelsted, S. L. Johnston, and H. Bisgaard. 2015. Association between respiratory infections in early life and later asthma is independent of virus type. J. Allergy Clin. Immunol. 136: 81-86.e4.
9. Walter, M. J., J. D. Morton, N. Kajiwara, E. Agapov, and M. J. Holtzman. 2002. Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J. Clin. Invest. 110: 165-175.
10. Kim, E. Y., J. T. Battaile, A. C. Patel, Y. You, E. Agapov, M. H. Grayson, L. A. Benoit, D. E. Byers, Y. Alevy, J. Tucker, et al. 2008. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med. 14: 633-640.
11. Byers, D. E., J. Alexander-Brett, A. C. Patel, E. Agapov, G. Dang-Vu, X. Jin, K. Wu, Y. You, Y. Alevy, J.-P. Girard, et al. 2013. Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J. Clin. Invest. 123: 3967-3982.
12. Wu, K., D. E. Byers, X. Jin, E. Agapov, J. Alexander-Brett, A. C. Patel, M. Cella, S. Gilfilan, M. Colonna, D. L. Kober, et al. 2015. TREM-2 promotes macrophage survival and lung disease after respiratory viral infection. J. Exp. Med. 212: 681-697.
13. Agapov, E., J. T. Battaile, R. Tidwell, R. Hachem, G. A. Patterson, R. A. Pierce, J. J. Atkinson, and M. J. Holtzman. 2009. Macrophage chitinase 1 stratifies chronic obstructive lung disease. Am. J. Respir. Cell Mol. Biol. 41: 379-384.
14. Alevy, Y. G., A. C. Patel, A. G. Romero, D. A. Patel, J. Tucker, W. T. Roswit, C. A. Miller, R. F. Heier, D. E. Byers, T. J. Brett, and M. J. Holtzman. 2012. IL- 13-induced airway mucus production is attenuated by MAPK13 inhibition. J. Clin. Invest. 122: 4555-4568.
15. Byers, D. E., K. Wu, G. Dang-Vu, X. Jin, E. Agapov, X. Zhang, J. T. Battaile, K. Schechtman, R. Yusen, R. A. Pierce, and M. J. Holtzman. 2018. Triggering receptor expressed on myeloid cells-2 expression tracks with M2-like macrophage activity and disease severity in COPD. Chest 153: 77-86.
16. Ishida, N., and M. Homma. 1978. Sendai virus. Adv. Virus Res. 23: 349-383.
17. Graham, B. S., M. D. Perkins, P. F. Wright, and D. T. Karzon. 1988. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26: 153-162.
18. Hashimoto, K., J. E. Durbin, W. Zhou, R. D. Collins, S. B. Ho, J. K. Kolls, P. J. Dubin, J. R. Sheller, K. Goleniewska, J. F. O'Neal, et al. 2005. Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J. Allergy Clin. Immunol. 116: 550-557.
19. Stokes, K. L., M. H. Chi, K. Sakamoto, D. C. Newcomb, M. G. Currier, M. M. Huckabee, S. Lee, K. Goleniewska, C. Pretto, J. V. Williams, et al. 2011. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/ c mice. J. Virol. 85: 5782-5793.
20. Empey, K. M., J. G. Orend, R. S. Peebles, Jr., L. Egaña, K. A. Norris, T. D. Oury, and J. K. Kolls. 2012. Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection. PLoS One 7: e40499.
21. Stier, M. T., M. H. Bloodworth, S. Toki, D. C. Newcomb, K. Goleniewska, K. L. Boyd, M. Quitalig, A. L. Hotard, M. L. Moore, T. V. Hartert, et al. 2016. Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin. J. Allergy Clin. Immunol. 138: 814-824.e11.
22. Bartlett, N. W., R. P. Walton, M. R. Edwards, J. Aniscenko, G. Caramori, J. Zhu, N. Glanville, K. J. Choy, P. Jourdan, J. Burnet, et al. 2008. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat. Med. 14: 199-204.
23. Newcomb, D. C., U. S. Sajjan, D. R. Nagarkar, Q. Wang, S. Nanua, Y. Zhou, C. L. McHenry, K. T. Hennrick, W. C. Tsai, J. K. Bentley, et al. 2008. Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice. Am. J. Respir. Crit. Care Med. 177: 1111-1121.
24. Wang, Q., D. J. Miller, E. R. Bowman, D. R. Nagarkar, D. Schneider, Y. Zhao, M. J. Linn, A. M. Goldsmith, J. K. Bentley, U. S. Sajjan, and M. B. Hershenson. 2011. MDA5 and TLR3 initiate pro-inflammatory signaling pathways leading to rhinovirus-induced airways inflammation and hyperresponsiveness. PLoS Pathog. 7: e1002070.
25. Han, M., J. Y. Hong, S. Jaipalli, C. Rajput, J. Lei, J. L. Hinde, Q. Chen, N. M. Hershenson, J. K. Bentley, and M. B. Hershenson. 2017. IFN-γ blocks development of an asthma phenotype in rhinovirus-infected baby mice by inhibiting type 2 innate lymphoid cells. Am. J. Respir. Cell Mol. Biol. 56: 242-251.
26. Zhang, Y., D. Mao, W. T. Roswit, X. Jin, A. C. Patel, D. A. Patel, E. Agapov, Z. Wang, R. M. Tidwell, J. J. Atkinson, et al. 2015. PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection. Nat. Immunol. 16: 1215-1227.
27. Huber, J. P., S. R. Gonzales-van Horn, K. T. Roybal, M. A. Gill, and J. D. Farrar. 2014. IFN-α suppresses GATA3 transcription from a distal exon and promotes H3K27 trimethylation of the CNS-1 enhancer in human Th2 cells. J. Immunol. 192: 5687-5694.
28. Eriksson, M., R. Bennet, and A. Nilsson. 2000. Wheezing following lower respiratory tract infections with respiratory syncytial virus and influenza A in infancy. Pediatr. Allergy Immunol. 11: 193-197.
29. Walsh, E. E., A. R. Falsey, and P. A. Hennessey. 1999. Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am. J. Respir. Crit. Care Med. 160: 791-795.
30. Papadopoulos, N. G., I. Christodoulou, G. Rohde, I. Agache, C. Almqvist, A. Bruno, S. Bonini, L. Bont, A. Bossios, J. Bousquet, et al. 2011. Viruses and bacteria in acute asthma exacerbations - a GA2 LEN-DARE systematic review. Allergy 66: 458-468.
31. Mandelcwajg, A., F. Moulin, C. Menager, F. Rozenberg, P. Lebon, and D. Gendrel. 2010. Underestimation of influenza viral infection in childhood asthma exacerbations. J. Pediatr. 157: 505-506.
32. Kumar, P. A., Y. Hu, Y. Yamamoto, N. B. Hoe, T. S. Wei, D. Mu, Y. Sun, L. S. Joo, R. Dagher, E. M. Zielonka, et al. 2011. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell 147: 525-538.
33. Zuo, W., T. Zhang, D.Z. Wu, S. P. Guan, A.-A. Liew, Y. Yamamoto, X. Wang, S. J. Lim, M. Vincent, M. Lessard, et al. 2015. p63+Krt5+ distal airway stem cells are essential for lung regeneration. Nature 517: 616-620.
34. Vaughan, A. E., A. N. Brumwell, Y. Xi, J. E. Gotts, D. G. Brownfield, B. Treutlein, K. Tan, V. Tan, F. C. Liu, M. R. Looney, et al. 2015. Lineagenegative progenitors mobilize to regenerate lung epithelium after major injury. Nature 517: 621-625.
35. Buchweitz, J. P., J. R. Harkema, and N. E. Kaminski. 2007. Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice. Toxicol. Pathol. 35: 424-435.
36. Wohlleben, G., J. Müller, U. Tatsch, C. Hambrecht, U. Herz, H. Renz, E. Schmitt, H. Moll, and K. J. Erb. 2003. Influenza A virus infection inhibits the efficient recruitment of Th2 cells into the airways and the development of airway eosinophilia. J. Immunol. 170: 4601-4611.
37. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4: 313-319.
38. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387.
39. McKenzie, G. J., C. L. Emson, S. E. Bell, S. Anderson, P. Fallon, G. Zurawski, R. Murray, R. Grencis, and A. N. McKenzie. 1998. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9: 423-432.
40. Szretter, K. J., A. L. Balish, and J. M. Katz. 2006. Influenza: propagation, quantification, and storage. Curr. Protoc. Microbiol. Chapter 15: Unit 15G.1.
41. Marino, D. J. 2012. Age-specific absolute and relative organ weight distributions for B6C3F1 mice. J. Toxicol. Environ. Health A 75: 76-99.
42. Lanford, R. E., C. Sureau, J. R. Jacob, R. White, and T. R. Fuerst. 1994. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology 202: 606-614.
43. Kawakami, E., T. Watanabe, K. Fujii, H. Goto, S. Watanabe, T. Noda, and Y. Kawaoka. 2011. Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. J. Virol. Methods 173: 1-6.
44. Rueden, C. T., J. Schindelin, M. C. Hiner, B. E. DeZonia, A. E. Walter, E. T. Arena, and K. W. Eliceiri. 2017. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics 18: 529.
45. Woods, J. C., C. K. Choong, D. A. Yablonskiy, J. Bentley, J. Wong, J. A. Pierce, J. D. Cooper, P. T. Macklem, M. S. Conradi, and J. C. Hogg. 2006. Hyperpolarized 3He diffusion MRI and histology in pulmonary emphysema. Magn. Reson. Med. 56: 1293-1300.
46. Jelley-Gibbs, D. M., D. M. Brown, J. P. Dibble, L. Haynes, S. M. Eaton, and S. L. Swain. 2005. Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation. J. Exp. Med. 202: 697-706.
47. Zammit, D. J., D. L. Turner, K. D. Klonowski, L. Lefrançois, and L. S. Cauley. 2006. Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity 24: 439-449.
48. Jelley-Gibbs, D. M., J. P. Dibble, D. M. Brown, T. M. Strutt, K. K. McKinstry, and S. L. Swain. 2007. Persistent depots of influenza antigen fail to induce a cytotoxic CD8 T cell response. J. Immunol. 178: 7563-7570.
49. Kim, T. S., M. M. Hufford, J. Sun, Y. X. Fu, and T. J. Braciale. 2010. Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection. J. Exp. Med. 207: 1161-1172.
50. Deslee, G., T. L. Adair-Kirk, T. Betsuyaku, J. C. Woods, C. H. Moore, D. S. Gierada, S. H. Conradi, J. J. Atkinson, H. M. Toennies, J. T. Battaile, et al. 2010. Cigarette smoke induces nucleic-acid oxidation in lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 43: 576-584.
51. Deslee, G., J. C. Woods, C. Moore, S. H. Conradi, D. S. Gierada, J. J. Atkinson, J. T. Battaile, L. Liu, G. A. Patterson, T. L. Adair-Kirk, et al. 2009. Oxidative damage to nucleic acids in severe emphysema. Chest 135: 965-974.
52. Deslee, G., J. C. Woods, C. M. Moore, L. Liu, S. H. Conradi, M. Milne, D. S. Gierada, J. Pierce, A. Patterson, R. A. Lewit, et al. 2009. Elastin expression in very severe human COPD. Eur. Respir. J. 34: 324-331.
53. Tyner, J. W., E. Y. Kim, K. Ide, M. R. Pelletier, W. T. Roswit, J. D. Morton, J. T. Battaile, A. C. Patel, G. A. Patterson, M. Castro, et al. 2006. Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J. Clin. Invest. 116: 309-321.
54. Patel, A. C., J. D. Morton, E. Y. Kim, Y. Alevy, S. Swanson, J. Tucker, G. Huang, E. Agapov, T. E. Phillips, M. E. Fuentes, et al. 2006. Genetic segregation of airway disease traits despite redundancy of chloride channel calcium-activated (CLCA) family members. Physiol. Genomics 25: 502-513.
55. Newcomb, D. C., M. G. Boswell, M. M. Huckabee, K. Goleniewska, D. E. Dulek, S. Reiss, N. W. Lukacs, J. K. Kolls, and R. S. Peebles, Jr. 2012. IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner. J. Immunol. 188: 1027-1035.
56. Newcomb, D. C., M. G. Boswell, T. P. Sherrill, V. V. Polosukhin, K. L. Boyd, K. Goleniewska, S. L. Brody, J. K. Kolls, K. B. Adler, and R. S. Peebles, Jr. 2013. IL-17A induces signal transducers and activators of transcription-6-independent airway mucous cell metaplasia. Am. J. Respir. Cell Mol. Biol. 48: 711-716.
57. Choy, D. F., K. M. Hart, L. A. Borthwick, A. Shikotra, D. R. Nagarkar, S. Siddiqui, G. Jia, C. M. Ohri, E. Doran, K. M. Vannella, et al. 2015. TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci. Transl. Med. 7: 301ra129.
58. Holtzman, M. J., H. L. Hahn, K. Sasaki, B.-E. Skoogh, P. D. Graf, L. M. Fabbri, and J. A. Nadel. 1982. Selective effect of general anesthetics on reflex bronchoconstrictor responses in dogs. J. Appl. Physiol. 53: 126-133.
59. Wang, W., N. M. Nguyen, E. Agapov, M. J. Holtzman, and J. C. Woods. 2012. Monitoring in vivo changes in lung microstructure with 3He MRI in Sendai virus-infected mice. J. Appl. Physiol. 112: 1593-1599.
60. McKinstry, K. K., T. M. Strutt, A. Buck, J. D. Curtis, J. P. Dibble, G. Huston, M. Tighe, H. Hamada, S. Sell, R. W. Dutton, and S. L. Swain. 2009. IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J. Immunol. 182: 7353-7363.
61. Wiley, J. A., A. Cerwenka, J. R. Harkema, R. W. Dutton, and A. G. Harmsen. 2001. Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology. Am. J. Pathol. 158: 119-130.
62. Chang, Y. J., H. Y. Kim, L. A. Albacker, H. H. Lee, N. Baumgarth, S. Akira, P. B. Savage, S. Endo, T. Yamamura, J. Maaskant, et al. 2011. Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. J. Clin. Invest. 121: 57-69.
63. Chang, Y. J., H. Y. Kim, L. A. Albacker, N. Baumgarth, A. N. McKenzie, D. E. Smith, R. H. Dekruyff, and D. T. Umetsu. 2011. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12: 631-638.
64. Stein, R. T., D. Sherrill, W. J. Morgan, C. J. Holberg, M. Halonen, L. M. Taussig, A. L. Wright, and F. D. Martinez. 1999. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354: 541-545.
65. Nguyen-Van-Tam, J. S., P. J. Openshaw, A. Hashim, E. M. Gadd, W. S. Lim, M. G. Semple, R. C. Read, B. L. Taylor, S. J. Brett, J. McMenamin, et al; Influenza Clinical Information Network (FLU-CIN). 2010. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax 65: 645-651.
66. Hogg, J. C., F. Chu, S. Utokaparch, R. Woods, W. M. Elliott, L. Buzatu, R. M. Cherniack, R. M. Rogers, F. C. Sciurba, H. O. Coxson, and P. D. Paré. 2004. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350: 2645-2653.
67. Kruger, S. J., S. K. Nagle, M. J. Couch, Y. Ohno, M. Albert, and S. B. Fain. 2016. Functional imaging of the lungs with gas agents. J. Magn. Reson. Imaging 43: 295-315.
68. Dunican, E. M., B. M. Elicker, D. S. Gierada, S. K. Nagle, M. L. Schiebler, J. D. Newell, W. W. Raymond, M. E. Lachowicz-Scroggins, S. Di Maio, E. A. Hoffman, et al; National Heart Lung and Blood Institute (NHLBI) Severe Asthma Research Program (SARP). 2018. Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction. J. Clin. Invest. 128: 997-1009.
69. Lajoie, S., I. P. Lewkowich, Y. Suzuki, J. R. Clark, A. A. Sproles, K. Dienger, A. L. Budelsky, and M. Wills-Karp. 2010. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat. Immunol. 11: 928-935.
70. Chambers, E. S., A. M. Nanzer, P. E. Pfeffer, D. F. Richards, P. M. Timms, A. R. Martineau, C. J. Griffiths, C. J. Corrigan, and C. M. Hawrylowicz. 2015. Distinct endotypes of steroid-resistant asthma characterized by IL-17A(high) and IFN-γ(high) immunophenotypes: potential benefits of calcitriol. J. Allergy Clin. Immunol. 136: 628-637.e4.
71. Willis, C. R., L. Siegel, A. Leith, D. Mohn, S. Escobar, S. Wannberg, K. Misura, E. Rickel, J. B. Rottman, M. R. Comeau, et al. 2015. IL-17RA signaling in airway inflammation and bronchial hyperreactivity in allergic asthma. Am. J. Respir. Cell Mol. Biol. 53: 810-821.
72. Ather, J. L., K. Ckless, R. Martin, K. L. Foley, B. T. Suratt, J. E. Boyson, K. A. Fitzgerald, R. A. Flavell, S. C. Eisenbarth, and M. E. Poynter. 2011. Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice. J. Immunol. 187: 64-73.
73. Roos, A. B., C. Sandén, M. Mori, L. Bjermer, M. R. Stampfli, and J. S. Erjefält. 2015. IL-17A is elevated in end-stage chronic obstructive pulmonary disease and contributes to cigarette smoke-induced lymphoid neogenesis. Am. J. Respir. Crit. Care Med. 191: 1232-1241.
74. Liu, W., S. Liu, M. Verma, I. Zafar, J. T. Good, D. Rollins, S. Groshong, M. M. Gorska, R. J. Martin, and R. Alam. 2017. Mechanism of TH2/TH17- predominant and neutrophilic TH2/TH17-low subtypes of asthma. J. Allergy Clin. Immunol. 139: 1548-1558.e4.
75. Yanagisawa, H., M. Hashimoto, S. Minagawa, N. Takasaka, R. Ma, C. Moermans, S. Ito, J. Araya, A. Budelsky, A. Goodsell, et al. 2017. Role of IL-17A in murine models of COPD airway disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 312: L122-L130.
76. Roos, A. B., S. Sethi, J. Nikota, C. T. Wrona, M. G. Dorrington, C. Sandén, C. M. T. Bauer, P. Shen, D. Bowdish, C. S. Stevenson, et al. 2015. IL-17A and the promotion of neutrophilia in acute exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 192: 428-437.
77. Wilson, R. H., G. S. Whitehead, H. Nakano, M. E. Free, J. K. Kolls, and D. N. Cook. 2009. Allergic sensitization through the airway primes Th17- dependent neutrophilia and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 180: 720-730.
78. Sichelstiel, A., K. Yadava, A. Trompette, O. Salami, Y. Iwakura, L. P. Nicod, and B. J. Marsland. 2014. Targeting IL-1b and IL-17A driven inflammation during influenza-induced exacerbations of chronic lung inflammation. PLoS One 9: e98440.
79. Hall, S. L., T. Baker, S. Lajoie, P. K. Richgels, Y. Yang, J. W. McAlees, A. van Lier, M. Wills-Karp, U. Sivaprasad, T. H. Acciani, et al. 2017. IL-17A enhances IL-13 activity by enhancing IL-13-induced signal transducer and activator of transcription 6 activation. J. Allergy Clin. Immunol. 139: 462-471.e14.
80. Yang, X. O., S. H. Chang, H. Park, R. Nurieva, B. Shah, L. Acero, Y.-H. Wang, K. S. Schluns, R. R. Broaddus, Z. Zhu, and C. Dong. 2008. Regulation of inflammatory responses by IL-17F. J. Exp. Med. 205: 1063-1075.
81. Busse, W. W., S. Holgate, E. Kerwin, Y. Chon, J. Feng, J. Lin, and S. L. Lin. 2013. Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am. J. Respir. Crit. Care Med. 188: 1294-1302.
82. Novartis Pharmaceuticals. 2018. Study to assess the efficacy and safety of CJM112 in patients with inadequately controlled severe asthma. In: ClinicalTrials. gov. National Library of Medicine (US), Bethesda, MD. NLM Identifier: NCT03299686. Available at http://clinicaltrials.gov/ct2/show/ NCT03299686. Accessed: August 29, 2018.
83. Xi, Y., T. Kim, A. N. Brumwell, I. H. Driver, Y. Wei, V. Tan, J. R. Jackson, J. Xu, D. K. Lee, J. E. Gotts, et al. 2017. Local lung hypoxia determines epithelial fate decisions during alveolar regeneration. Nat. Cell Biol. 19: 904-914.
84. Ray, S., N. Chiba, C. Yao, X. Guan, A. M. McConnell, B. Brockway, L. Que, J. L. McQualter, and B. R. Stripp. 2016. Rare SOX2+ airway progenitor cells generate KRT5+ cells that repopulate damaged alveolar parenchyma following influenza virus infection. Stem Cell Reports 7: 817-825.
85. Wenzel, S., L. Ford, D. Pearlman, S. Spector, L. Sher, F. Skobieranda, L. Wang, S. Kirkesseli, R. Rocklin, B. Bock, et al. 2013. Dupilumab in persistent asthma with elevated eosinophil levels. N. Engl. J. Med. 368: 2455-2466.
86. Castro, M., J. Corren, I. D. Pavord, J. Maspero, S. Wenzel, K. F. Rabe, W. W. Busse, L. Ford, L. Sher, J. M. FitzGerald, et al. 2018. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N. Engl. J. Med. 378: 2486-2496.
87. Rabe, K. F., P. Nair, G. Brusselle, J. F. Maspero, M. Castro, L. Sher, H. Zhu, J. D. Hamilton, B. N. Swanson, A. Khan, et al. 2018. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N. Engl. J. Med. 378: 2475-2485.
88. Corren, J., R. F. Lemanske, N. A. Hanania, P. E. Korenblat, M. V. Parsey, J. R. Arron, J. M. Harris, H. Scheerens, L. C. Wu, Z. Su, et al. 2011. Lebrikizumab treatment in adults with asthma. N. Engl. J. Med. 365: 1088-1098.
89. Russell, R. J., L. Chachi, J. M. FitzGerald, V. Backer, R. Olivenstein, I. L. Titlestad, C. S. Ulrik, T. Harrison, D. Singh, R. Chaudhuri, et al; MESOS study investigators. 2018. Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial. Lancet Respir. Med. 6: 499-510.
90. Panettieri, R. A., Jr., U. Sjöbring, A. Péterffy, P. Wessman, K. Bowen, E. Piper, G. Colice, and C. E. Brightling. 2018. Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebocontrolled, phase 3 clinical trials. Lancet Respir. Med. 6: 511-525.
91. Kitaguchi, Y., Y. Komatsu, K. Fujimoto, M. Hanaoka, and K. Kubo. 2012. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int. J. Chron. Obstruct. Pulmon. Dis. 7: 283-289.
92. Bafadhel, M., S. McKenna, S. Terry, V. Mistry, M. Pancholi, P. Venge, D. A. Lomas, M. R. Barer, S. L. Johnston, I. D. Pavord, and C. E. Brightling. 2012. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am. J. Respir. Crit. Care Med. 186: 48-55.
93. Christenson, S. A., K. Steiling, M. van den Berge, K. Hijazi, P. S. Hiemstra, D. S. Postma, M. E. Lenburg, A. Spira, and P. G. Woodruff. 2015. Asthma- COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 191: 758-766.
94. Pavord, I. D., P. Chanez, G. J. Criner, H. A. M. Kerstjens, S. Korn, N. Lugogo, J.-B. Martinot, H. Sagara, F. C. Albers, E. S. Bradford, et al. 2017. Mepolizumab for eosinophilic chronic obstructive pulmonary disease. N. Engl. J. Med. 377: 1613-1629.
95. Gauvreau, G. M., P. M. O'Byrne, L. P. Boulet, Y. Wang, D. Cockcroft, J. Bigler, J. M. FitzGerald, M. Boedigheimer, B. E. Davis, C. Dias, et al. 2014. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N. Engl. J. Med. 370: 2102-2110.
96. GlaxoSmithKline. 2017. Efficacy and safety study of GSK3772847 in subjects with moderately severe asthma. In: ClinicalTrials.gov. National Library of Medicine (US), Bethesda, MD. NLM Identifier: NCT03207243. Available at: https://clinicaltrials.gov/ct2/show/NCT03207243. Accessed: August 29, 2018.